Clinical trial

Open Label, Multicenter, Real World Practice of Durvalumab (Imfinzi PMS)

NCT04068168

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2020-01-30

PhaseN/A

Study timeline

Study start (actual)2020-01-30Date precision: day

Registry last updated2025-11-17

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Cancer, Biliary Tract Cancerunresolved

Interventions

Sponsors & collaborators

AstraZenecalead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT04068168 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.